Anorectic effect of alpha 2-antagonists in dog: effect of acute and chronic treatment

Pharmacol Biochem Behav. 1991 Jun;39(2):313-20. doi: 10.1016/0091-3057(91)90185-5.

Abstract

Acute oral administration of alpha 2-antagonists (yohimbine, RX 821002, atipamezole: 1 mg/kg each) reduced dog food intake. Yohimbine reduced food intake over 20 hours, while the effect of the two other drugs lasted only 2 hours. Yohimbine (0.4 or 1 microgram/kg) gave the same results. At these doses, it promoted a lasting durable increase in plasma nonesterified fatty acids and catecholamines levels and a transient elevation of plasma insulin levels. The beta-antagonist nadolol (4 mg/kg per os) suppressed the yohimbine-induced lipid mobilization without modifying its anorectic effect. Chronic oral yohimbine (0.4 mg/kg/day during 14 days) reduced food intake and promoted a weight loss. Normal food intake was recovered two days after yohimbine withdrawal. No change was observed in the number of platelet alpha 2-adrenergic receptors. In addition to their lipid mobilizing action and sympathetic tone stimulation, alpha 2-antagonist compounds reduce food intake.

MeSH terms

  • Adrenergic alpha-Antagonists / pharmacology*
  • Animals
  • Appetite Depressants / pharmacology*
  • Blood Glucose / metabolism
  • Blood Platelets / drug effects
  • Blood Platelets / metabolism
  • Body Weight / drug effects
  • Catecholamines / blood
  • Cell Membrane / drug effects
  • Cell Membrane / metabolism
  • Dioxanes / pharmacology
  • Dogs
  • Fatty Acids, Nonesterified / blood
  • Feeding Behavior / drug effects
  • Idazoxan / analogs & derivatives
  • Imidazoles / pharmacology
  • Insulin / blood
  • Male
  • Nadolol / pharmacology
  • Yohimbine / pharmacology

Substances

  • Adrenergic alpha-Antagonists
  • Appetite Depressants
  • Blood Glucose
  • Catecholamines
  • Dioxanes
  • Fatty Acids, Nonesterified
  • Imidazoles
  • Insulin
  • atipamezole
  • Yohimbine
  • Nadolol
  • 2-methoxyidazoxan
  • Idazoxan